Tim-3 Agonist Limits ILC2, Eases Airway Reactivity
In a groundbreaking study set to redefine the therapeutic landscape for respiratory diseases, researchers have unveiled the remarkable potential of ...
In a groundbreaking study set to redefine the therapeutic landscape for respiratory diseases, researchers have unveiled the remarkable potential of ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine